Targeting the IL-17 pathway in inflammatory disorders

Cong-Qiu Chu

Research output: Book/ReportBook

Abstract

This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.

Original languageEnglish (US)
PublisherSpringer International Publishing
Number of pages102
ISBN (Electronic)9783319280400
ISBN (Print)9783319280394
DOIs
StatePublished - Jan 1 2016

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Targeting the IL-17 pathway in inflammatory disorders'. Together they form a unique fingerprint.

  • Cite this